Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves' ophthalmopathy

被引:23
|
作者
Terwee, CB
Dekker, FW
Bonsel, GJ
Heisterkamp, SH
Prummel, MF
Baldeschi, L
Wiersinga, WM
机构
[1] VU Med Ctr, Inst Res Extramural Med, EMGO Inst, NL-1081 BT Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Orbital Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1046/j.1365-2265.2003.01695.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The importance of facial disfigurement in many diseases necessitates a reliable and valid measure of disfigurement severity for clinical studies. The hypothesis is that a universal concept of disfigurement exists and can be measured in a reliable way. The objectives of this study were to investigate if persons, in particular patients and physicians, can agree on facial disfigurement severity; and to determine the relative contribution of predefined clinical characteristics of patients with Graves' ophthalmopathy (GO) to the overall rating of facial disfigurement severity. DESIGN A panel study was carried out in four different panels, each consisting of four members. PATIENTS We randomly selected 100 slide pairs of GO patients from four available study populations, involving mild, moderate and severe GO patients (mean age 49 years, 76% female) who were treated with either radiotherapy, sham-irradiation, prednisone or orbital decompression. MEASUREMENTS All panel members individually scored the disfigurement severity of 100 GO patients shown on standardized slides on a Visual Analog Scale. In total, 1600 ratings were collected. We calculated within- and between-panel agreement of disfigurement severity and identified determinants of disfigurement. RESULTS Agreement within a panel varied from 0.65 to 0.79 and was highest within the panel of ophthalmologists. Between-panel agreement was 0.67 and was highest between ophthalmologists and laypersons. Compared with the global average, patients overrated and endocrinologists underrated disfigurement severity. Female panellists rated the patients, on average, more disfigured than male panellists. Important determinants of disfigurement were eyelid retraction, severe eyelid swelling and proptosis. Their relative importance was consistent across panels and in contrast to current measures of GO severity. CONCLUSION Facial disfigurement severity can be measured in a reliable way using panels of panellists. Except for some systematic differences between panellists, facial disfigurement does not seem to be in the eye of the beholder.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [41] Tear Film Osmolarity in Patients with Graves Ophthalmopathy
    Turkyilmaz, Kemal
    Oner, Veysi
    Sahin, Serap Baydur
    Cure, Erkan
    Cure, Cumhur
    Kola, Mehmet
    Durmus, Mustafa
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2014, 11 (01): : 15 - 19
  • [42] IMPORTANCE OF ELECTROPHYSIOLOGY IN CONTROLLING PATIENTS WITH GRAVES OPHTHALMOPATHY
    WEIK, R
    RUPRECHT, KW
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1995, 206 (06) : 446 - 450
  • [43] ANTIBODIES AGAINST EYE MUSCLE MEMBRANE-ANTIGENS IN GRAVES OPHTHALMOPATHY
    SIKORSKA, H
    MILLER, A
    GHAHREMANI, M
    WALL, JR
    CLINICAL RESEARCH, 1984, 32 (02): : A273 - A273
  • [44] FAILURE TO DETECT EYE MUSCLE MEMBRANE SPECIFIC AUTOANTIBODIES IN GRAVES OPHTHALMOPATHY
    SIKORSKA, H
    WALL, JR
    BRITISH MEDICAL JOURNAL, 1985, 291 (6495): : 604 - 604
  • [45] Evaluation of the national eye institute visual function questionnaire in Graves' ophthalmopathy
    Bradley, Elizabeth A.
    Sloan, Jeff A.
    Novotny, Paul J.
    Garrity, James A.
    Woog, John J.
    West, Sheila K.
    OPHTHALMOLOGY, 2006, 113 (08) : 1450 - 1454
  • [46] Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease
    Jarusaitiene, Dalia
    Verkauskiene, Rasa
    Jasinskas, Vytautas
    Jankauskiene, Jurate
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2016, 2016
  • [47] A NEW OPHTHALMOPATHY INDEX FOR QUANTITATION OF EYE CHANGES OF GRAVES-DISEASE
    BARTALENA, L
    MARCOCCI, C
    BOGAZZI, F
    BRUNOBOSSIO, G
    LEPRI, A
    BAGNOLESI, P
    PINCHERA, A
    ACTA ENDOCRINOLOGICA, 1989, 121 : 190 - 192
  • [48] Extraocular muscle changes in Graves' ophthalmopathy - Saccadic eye movements.
    Schworm, HD
    Ygge, J
    Rydberg, A
    Tian, S
    Bolzani, R
    Lennerstrand, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S416 - S416
  • [49] Beauty Is in the Eye of the Beholder: Esthetic Outcome Assessment in Smile Reanimation Surgery in Patients With Facial Palsy
    van Veen, Martinus M.
    Broekstra, Dieuwke C.
    Mureau, Marc A. M.
    Werker, Paul M. N.
    Dijkstra, Pieter U.
    JOURNAL OF CRANIOFACIAL SURGERY, 2021, 32 (01) : 159 - 163
  • [50] The effect of etanercept on Graves' ophthalmopathy: a pilot study
    Paridaens, D
    van den Bosch, WA
    van der Loos, TL
    Krenning, EP
    van Hagen, PM
    EYE, 2005, 19 (12) : 1286 - 1289